Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Resuscitation
|
July 23, 2022
Evaluation of telephone-assisted cardiopulmonary resuscitation recommendations for out-of-hospital cardiac arrest
Angel Guerrero, Audrey L Blewer, Anjni P Joiner, et al.
Clinical Breast Cancer
|
May 19, 2007
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial
Andreas Schneeweiss, Ilka Lauschner, Amparo Ruiz, et al.
The Oncologist
|
July 12, 2020
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Miguel Martin, Angel Guerrero-Zotano, Ángel Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER<sup>+</sup>/HER2<sup>+</sup> Breast Cancers: Implications to the ExteNET Trial
Dhivya R Sudhan, Luis J Schwarz, Angel Guerrero-Zotano, et al.
BMC Cancer
|
February 11, 2010
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
Zaida Garcia-Casado, Angel Guerrero-Zotano, Antonio Llombart-Cussac, et al.
Genetic Testing and Molecular Biomarkers
|
April 12, 2018
Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women
Alejandrina Muñoz-Palomeque, Miguel Angel Guerrero-Ramirez, Lidia Ariadna Rubio-Chavez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2021
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER<sup>+</sup> Breast Cancer
Alberto Servetto, Rahul Kollipara, Luigi Formisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study
Miguel Martín, Sibylle Loibl, Gunter von Minckwitz, et al.
Journal of the National Cancer Institute
|
October 24, 2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression
Luis J Schwarz, Katherine E Hutchinson, Brent N Rexer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial
Komal Jhaveri, Lisa D Eli, Sara A Hurvitz, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Resuscitation
|
July 23, 2022
Evaluation of telephone-assisted cardiopulmonary resuscitation recommendations for out-of-hospital cardiac arrest
Angel Guerrero, Audrey L Blewer, Anjni P Joiner, et al.
Clinical Breast Cancer
|
May 19, 2007
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial
Andreas Schneeweiss, Ilka Lauschner, Amparo Ruiz, et al.
The Oncologist
|
July 12, 2020
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Miguel Martin, Angel Guerrero-Zotano, Ángel Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER<sup>+</sup>/HER2<sup>+</sup> Breast Cancers: Implications to the ExteNET Trial
Dhivya R Sudhan, Luis J Schwarz, Angel Guerrero-Zotano, et al.
BMC Cancer
|
February 11, 2010
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
Zaida Garcia-Casado, Angel Guerrero-Zotano, Antonio Llombart-Cussac, et al.
Genetic Testing and Molecular Biomarkers
|
April 12, 2018
Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women
Alejandrina Muñoz-Palomeque, Miguel Angel Guerrero-Ramirez, Lidia Ariadna Rubio-Chavez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2021
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER<sup>+</sup> Breast Cancer
Alberto Servetto, Rahul Kollipara, Luigi Formisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study
Miguel Martín, Sibylle Loibl, Gunter von Minckwitz, et al.
Journal of the National Cancer Institute
|
October 24, 2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression
Luis J Schwarz, Katherine E Hutchinson, Brent N Rexer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial
Komal Jhaveri, Lisa D Eli, Sara A Hurvitz, et al.
Page
of 9